GB:0UJF's free cash flow for Q2 2022 was $-27.79M. For the 2022 fiscal year, GB:0UJF's free cash flow was decreased by $-81.99M and operating cash flow was $-27.87M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Operating Cash Flow	$ -140.79M	$ -157.69M	$ -69.86M	$ -63.59M	$ -51.61M	$ -41.17M
Investing Cash Flow	$ -45.69M	$ -103.87M	$ -158.19M	$ 7.78M	$ -65.00K	$ -8.00M
Financing Cash Flow	$ 216.55M	$ 221.11M	$ 194.38M	$ 243.85M	$ 4.01M	$ 175.15M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 573.66M	$ 231.90M	$ 272.35M	$ 306.02M	$ 117.97M	$ 165.63M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	$ 21.00K	$ 257.00K	$ 261.00K	$ 59.00K	$ 0.00	-
Issuance Of Capital Stock	$ 196.74M	$ 196.74M	$ 187.73M	$ 223.12M	$ 0.00	-
Issuance Of Debt	-	-	-	-	-	-
Repayment Of Debt	-	-	-	$ -127.00K	$ 0.00	-
Free Cash Flow	$ -140.89M	$ -159.19M	$ -77.20M	$ -63.69M	$ -51.69M	$ -41.19M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Aurinia Pharmaceuticals Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing